global Central Nervous System Therapeutic market size is expected to be worth around US$ 305.0 billion by 2030, according to a new report by Vision Research Reports.
The global Central Nervous System Therapeutic market size was valued at US$ 216.2 billion in 2020 and is anticipated to grow at a CAGR of 17.4% during forecast period 2021 to 2030.
The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. High unmet medical needs and government initiatives to reduce the disease burden are driving the market for central nervous system (CNS) therapeutic over the forecast period. According to WHO, the global economy loses due to depression and anxiety is more than USD 1 trillion per year and rising patient base of mental health globally is expected to increase the economy loses by USD 16 trillion in 2030.
The market holds strong future growth opportunities and major players are adopting different marketing strategies such as new product development, collaborations, geographic expansion, mergers and acquisitions, and new product approval, to strengthen their positions. In February 2020, Biogen announced the investment in Sangamo’s zinc finger platform to develop therapies for Alzheimer’s disease and other neurological diseases. Similarly, the company has an agreement with Ionis Pharmaceutical for the development of drug candidates applicable across a wide range of neurological diseases.
Presence of strong pipeline products by major pharmaceutical companies such as Biogen, H. Lundbeck A/S, Eli Lilly and Company, and others are expected to accelerate market growth over the forecast period. Besides, other pharmaceutical companies are also actively involved in the development of novel therapies and investing heavily to develop effective therapeutics for the treatment of CNS associated diseases.
Most of the late phase development drugs are for the treatment of neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis. The drug candidates such as aducanumab, brexpiprozole, evobrutinib, solanezumab are some of the potential drugs that could be commercialized in the next five to eight years for the treatment of various indication of neurodegenerative disorders. Apart from neurodegenerative diseases, migraine, schizophrenia, and epilepsy are the major CNS disease indications that have potential drug candidates in pipeline.
The cancer segment is expected to witness the fastest growth rate over the forecast period. Increasing prevalence, high mortality rate, and rising demand for effective treatment are expected to fuel the growth of the market for CNS therapeutic. According to National Cancer Institute estimates, the number of new cases of CNS cancers was 23,890 whereas the number of deaths was 18,020 in the U.S. in 2020.
The neurodegenerative disease segment dominated the market for central nervous system therapeutic and accounted for the largest revenue share of 39.4% in 2020. The segment is expected to continue its dominance over the forecast period. The high prevalence of neurodegenerative diseases such as multiple sclerosis, Alzheimer’s disease, and Parkinson’s disease and the high cost of neurodegenerative diseases is anticipated to increase the segment share from the year 2020 to 2028. Moreover, strong pipeline products for the treatment of neurodegenerative disease are expected to drive the segment. For instance, there are more than 130 drug candidates in the pipeline globally for the treatment of Alzheimer’s disease.
Mental health was estimated to be the second-largest segment in the central nervous system therapeutic market. High patient base of anxiety disorder and epilepsy are the major growth contributors. Moreover, the presence of strong pipeline drugs for the treatment of psychotic disorders is anticipated to drive the market for central nervous system therapeutic at a lucrative rate over the forecast period.
CNS cancer is expected to be the fastest-growing segment over the forecast period and is projected to exhibit a CAGR of 10.1%. Its high growth rate can be attributed to increasing prevalence and mortality and growing demand for treatment. For instance, around 70,800 people in the United States are diagnosed with brain cancer every year, which represents 1.4% of the total cancer incidence and causes about 2.4% of all cancer deaths in the U.S. GBM is the most common brain cancer and accounts for more than half of all brain cancers. In 2018, around 300,000 people were diagnosed with brain cancer worldwide and caused deaths of nearly 240,000 in the same year. Also, constant R&D efforts by pharmaceutical companies, coupled with increasing investment by government and private entities, are expected to support the adoption of CNS drugs in cancer treatment.
The neurodegenerative diseases and mental health segments collectively held more than 75.0% share of the market. High prevalence and technological collaborations are factors that can be attributed to the largest share of these segments and will continue to show its dominance over the forecast period. For instance, in January 2021, Atalanta Therapeutics has collaborated with Biogen and Genentech for the development of RNAi therapeutics for the treatment of Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease.
North America dominated the market for central nervous system therapeutic and held the largest revenue share of 47.3% in 2020. The presence of strong players in the region and rising initiative undertaken by key players to develop novel therapies for different central nervous system disorders are factors expected to increase the overall market share. Moreover, the constantly rising incidence of mental health and neurodegenerative disorders such as multiple sclerosis, Alzheimer’s, Parkinson’s disease, and epilepsy is fueling the demand for central nervous system therapeutics in the North America region. Awareness campaigns about diagnosis and treatment of CNS diseases run by pharmaceutical companies and better reimbursement policies for the CNS diseases treatment increase the treatment rate in the region.
In Asia Pacific, the market for central nervous system therapeutic is expected to grow at the highest rate over the next eight years. Improving healthcare infrastructure in emerging markets such as India and China and a large patient base with high unmet medical needs are some factors expected to drive treatment adoption rate during the forecast period. Moreover, increasing awareness regarding mental health and initiatives of the government and non-profit organizations are increasing market growth. In countries like China and India, many non-profit organizations offer treatment for patients living with central nervous system disorders.
Otsuka Pharmaceutical Co., Ltd.
Eli Lilly and Company
Merck & Co.
Teva Pharmaceutical Industries Ltd.
Johnson & Johnson Services, Inc.
Amyotrophic Lateral Sclerosis
Middle East & Africa
The Central Nervous System Therapeutic market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Central Nervous System Therapeutic market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Central Nervous System Therapeutic market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Central Nervous System Therapeutic market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Central Nervous System Therapeutic market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Central Nervous System Therapeutic capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Central Nervous System Therapeutic by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Central Nervous System Therapeutic market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Central Nervous System Therapeutic market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Central Nervous System Therapeutic market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Central Nervous System Therapeutic industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Central Nervous System Therapeutic market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Central Nervous System Therapeutic market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Central Nervous System Therapeutic market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Central Nervous System Therapeutic market. These factors have benefited the growth of the global market for Central Nervous System Therapeutic. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Central Nervous System Therapeutic. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Central Nervous System Therapeutic are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Astaxanthin Market (By Source: Natural, Synthetic; By Product: Dried Algae Meal or Biomass, Oil, Softgel, Liquid, Others; By Application: Nutraceuticals, Cosmetics, Aquaculture and AnimalFeed, Food) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Vascular Grafts Market (By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts; By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease; By Raw Material: Polyester Vascular Grafts, Polytetrafluoroethylene Vascular Grafts) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Biotechnology Instruments Market (By Product: Lab Automation Instruments, Life Science Consumables, IVD Instruments, Medical Lasers; By End-use: Government & Academic Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Facilities, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Cone Beam Computed Tomography Market (By Application: Dental Implantology, Oral and Maxillofacial Surgery, Orthodontics, Endodontics, General Dentistry, Temporomandibular Joint (TMJ) Disorders, Periodontics, Forensic Dentistry, Others; By Patient Position: Standing Position, Seated Position, Supine Position; By End-use: Hospitals & Others, Dental Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Aquaculture Vaccines Market (By Product: Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines; By Route Of Administration: Oral, Injected, Immersion & Spray; By Application: Bacterial, Viral, Parasitic) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...